3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
15
Breast Neoplasms
14
Sarcoma
11
Squamous Cell Carcinoma of Head and Neck
10
Glioblastoma
10
Esophageal Neoplasms
9
Rectal Neoplasms
8
Stomach Neoplasms
7
Urinary Bladder Neoplasms
6
Neoplasms
6
Carcinoma, Hepatocellular
6
Pancreatic Neoplasms
5
Colorectal Neoplasms
5
Brain Neoplasms
5
Oropharyngeal Neoplasms
4
Lung Neoplasms
4
Hypopharyngeal Neoplasms
4
Head and Neck Neoplasms
4
Glioma
4
Recurrence
3
Prostatic Neoplasms
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Neoplasm Metastasis
3
Mouth Neoplasms
3
Melanoma
3
Colonic Neoplasms
3
Astrocytoma
3
Triple Negative Breast Neoplasms
2
Thyroid Neoplasms
2
Skin Neoplasms
2
Interventions
Nivolumab
6
Specimen Handling
5
Magnetic Resonance Spectroscopy
4
Gemcitabine
4
Cisplatin
4
pembrolizumab
3
cabozantinib
3
avelumab
3
Ipilimumab
3
Carboplatin
3
CTLA-4 Antigen
3
enfortumab vedotin
2
Immunoglobulin G
2
Disulfides
2
Biopsy
2
tremelimumab
1
trastuzumab deruxtecan
1
tocilizumab
1
tamibarotene
1
relatlimab
1
eribulin
1
erdafitinib
1
durvalumab
1
atezolizumab
1
Propranolol
1
Platinum
1
Leucovorin
1
Lenalidomide
1
Fluorouracil
1
Etoposide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Urethral Neoplasms
×
Surgical Procedures, Operative
×
1 year
×
Clear all
No trials found.